Oncusp Therapeutics Receives FDA Fast Track Designation For CUSP06 For The Treatment Of Platinum-Resistant Ovarian Cancer
"We are extremely pleased that the FDA granted Fast Track Designation to CUSP06," said Eric Slosberg, PhD, Chief Development Officer of OnCusp Therapeutics. "The early results from our Phase 1 trial ...
Tears as mum battling 'vile' stage four cancer fights for tickets to Black Sabbath in Birmingham
Dedicated Black Country nurse Coz Smith, 63, was known as the 'Queen of the Mosh Pit' when she wasn't hard at work caring for ...
EurekAlert!12m
Ovarian cancer discovery could turn failed treatment into lifesaver (IMAGE)
UVA Health's Melanie Rutkowski, PhD, and her team are expanding our understanding of the microbiome and how it influences diseases such as breast and ovarian cancer. May be used to accompany news ...
Multiple Sclerosis News Today34m
Australia, New Zealand get consensus guidelines for MS care
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...